Company: CI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001739940-25-000009
Chunk: 772

Company: Cigna Group
Filing Date: 2025-02-27
Form: 10-K
Item: Item 13
Chunk 772
---
., Ph.D.Director/s/ Philip O. Ozuah, M.D., Ph.D.Philip O. Ozuah, M.D., Ph.D.Director/s/ Kimberly A. Ross   Kimberly A. Ross Director/s/ Eric C. Wiseman   Eric C. Wiseman Lead Independent Director/s/ Donna F. Zarcone   Donna F. Zarcone  Director

121

THE CIGNA GROUP AND SUBSIDIARIES

INDEX TO FINANCIAL STATEMENT SCHEDULES   PAGESchedules  ICondensed Financial Information of The Cigna Group (Registrant)FS-2  Statements of Income for the Years Ended December 31, 2024, 2023 and 2022FS-2  Balance Sheets as of December 31, 2024 and 2023FS-3  Statements of Cash Flows for the Years Ended December 31, 2024, 2023 and 2022FS-4  Notes to Condensed Financial StatementsFS-5 IIValuation and Qualifying Accounts and Reserves for the Years Ended December 31, 2024, 2023 and 2022FS-7

Schedules other than those listed above are omitted because they are not required or are not applicable, or the required information is shown in the financial statements or notes thereto.

FS-1

THE CIGNA GROUP AND SUBSIDIARIESSCHEDULE ICONDENSED FINANCIAL INFORMATION OF THE CIGNA GROUP(REGISTRANT)STATEMENTS OF INCOME For the Years Ended December 31,(In millions)202420232022RevenuesNet investment income and other revenue$26 $22 $5 Intercompany interest income469 516 478 Total revenues495 538 483 Operating expensesSelling, general and administrative expenses14 2 2 Total operating expenses14 2 2 Income from operations481 536 481 Interest expense and other (1,388)(1,332)(1,215)Intercompany interest expense(2)(118)(147)Loss before income taxes(909)(914)(881)Income tax benefits(189)(192)(183)Loss of parent company(720)(722)(698)Equity in income of subsidiaries4,154 5,886 7,402 Shareholders' net income3,434 5,164 6,704 Share